Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Bariatric Bypass Achieves Greater Cholesterol Lowering
Cholesterol affected independent of weight loss, glucose metabolism, insulin resistance

TUESDAY, June 11 (HealthDay News) -- Compared to gastric banding, bariatric bypass surgery achieves greater cholesterol lowering, according to a study published in the June issue of Diabetes Care.

Alberto Benetti, M.D., from Universita degli Studi di Milano, and colleagues assessed glucose metabolism (blood glucose and serum insulin levels and homeostasis model assessment of insulin resistance [HOMA-IR] index) and cholesterol metabolism (absorption: serum campesterol and sitosterol levels; synthesis: serum lathosterol levels; catabolism: rate of appearance and serum concentrations of serum 7-α- and serum 27-OH-cholesterol after infusions of deuterated 7-α- and 27-OH-cholesterol in sequence) in grade 3 obesity subjects undergoing bariatric bypass surgery and gastric banding. Measurements were taken before and six months after surgery.

The researchers found that baseline values were similar in all subjects. In both groups, weight loss and blood glucose, insulin levels, HOMA-IR, and triglycerides decreased similarly. Serum cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, serumsitosterol, and campesterol levels decreased and lathosterol levels increased only in bypass subjects. Serum 27-OH-cholesterol decreased in both groups, but only in the bypass group was there a significant increase in 7-α-OH-cholesterol.

"Malabsorptive surgery specifically affects cholesterol levels, independent of weight loss and independent of glucose metabolism and insulin resistance," the authors write.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.

April 20, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

AMA Examines Economic Impact of Physicians

White House: 8 Million People Signed Up for Health Insurance

Int'l Medical Education Standards Not Equivalent to U.K. Standards

Standard Ultrasound Criteria Needed in Carotid Artery Stenosis CME

Salmonella Cases Dip but Food Poisoning Rates Remain High

One in 20 U.S. Adults a Victim of Diagnostic Errors